CLASS IIDrug recall · Reported 7 Feb 2018 · FDA Enforcement Report
Stree Overlord capsules, 3800 mg, labeling is in foreign language recalled
A&H Focal is recalling Stree Overlord capsules, 3800 mg, labeling is in foreign language, distributed in New Jersey, New York. The recall was initiated on 7 Mar 2017 and the FDA has classified it as Class II.
Check your package
Lot, batch or date codesAll Lots
Quantity recalledunknown
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Products marketed as supplements sometimes contain undeclared prescription drug ingredients such as sildenafil or sibutramine. These can interact dangerously with other medicines.
Product as listed by the FDA
STREE OVERLORD capsules, 3800 mg, 4-count bottle, labeling is in foreign language
Where it was distributed
NY and NJ through six retail stores named "Asian Food Markets"
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Which lots are affected?
All Lots
Where was it sold?
NY and NJ through six retail stores named "Asian Food Markets"
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.